Login
Toggle navigation
Videos
Categories
Trending
Lori Woods, CEO of Isoray, Inc.
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Isoray Discusses CEO Transition, Vision for the Company and Value Catalysts Moving Forward
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Simplifying and Enhancing Your 401(k) Experience with EVOadvisers | Dave O'Brien , Founder, EVOadvisers.
00:10:00
Acme Lithium: Advancing North America's Domestic Lithium Supply
00:10:00
Driving Digital Transformation: Revolutionizing Consumer Engagement and Decision-Making at OBL|Mr. Aditya Gupta,Chief Executive Officer,Orient Bell Ltd.
00:10:00
Resilience Amid Turmoil, Seizing New Horizons | Eu Chin Fen , CEO, Frasers Hospitality Trust.
00:10:00
Interview with Anthony Purcell, Vice President of Sales for Asia at Aspen Aerogels, Inc.|Donald R. Young is President, Chief Executive Officer & Director, Aspen Aerogels, Inc.
00:10:00
Ankit Mehta Discusses the Transformative Role of Drones in the Tourism Sector | Ankit Mehta , CEO, ideaForge Technology Ltd.
00:10:00
Woodlawn Project: Premier Zinc-Copper-Lead-Silver Development in Australia
00:10:00
Hecla Mining Labor Strike and Project Updates
00:10:00
Zoom2u CEO Steve Orenstein on Revolutionizing Same-Day Delivery and Expanding SaaS Solutions | Steve Orenstein , CEO , Zoom2u Technologies Ltd.
00:10:00
Ali Haji, CEO of ION Energy, highlights the company's story and the promising potential for lithium in Mongolia during an interview with Bloomberg Mongolia at the PDAC2024 Conference in Toronto, Canada.|ALI HAJI CEO, Director of ION Energy Ltd
00:10:00
Foremost Lithium's Exciting Year Ahead: Maiden Drill Program and Strategic Developments
00:10:00
Lumina Group Showcases Ecuadorian Gold Projects at One-to-One Conference